Wolverine Trading’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,500
Closed -$768K 6046
2025
Q2
$768K Buy
13,500
+1,000
+8% +$56.5K ﹤0.01% 2559
2025
Q1
$751K Buy
12,500
+2,400
+24% +$164K ﹤0.01% 2522
2024
Q4
$818K Sell
10,100
-5,300
-34% -$453K ﹤0.01% 2867
2024
Q3
$1.22M Buy
15,400
+9,900
+180% +$703K ﹤0.01% 2161
2024
Q2
$336K Sell
5,500
-5,900
-52% -$351K ﹤0.01% 3262
2024
Q1
$563K Buy
+11,400
New +$543K ﹤0.01% 2719

Other funds holding PRCT

Wolverine Trading's PRCT Position: Q3 2025 in Review

Wolverine Trading increased its Procept Biorobotics (PRCT) stake by 81% in Q3 2025, buying an estimated $150K and bringing the position to 7,378 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #4540.

Wolverine Trading first reported a position in PRCT in Q3 2023 and has held it in 8 quarters since. The position peaked at $697K in Q3 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Wolverine Trading held 7,378 shares of Procept Biorobotics worth $269K as of Q3 2025.
  • Wolverine Trading bought 3,294 Procept Biorobotics shares in Q3 2025, an estimated $150K.
  • Procept Biorobotics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4540 holding.
  • Wolverine Trading first reported a position in Procept Biorobotics in Q3 2023 and has held it in 8 quarters since.
  • Wolverine Trading's Procept Biorobotics position peaked at $697K in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.